SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-021722
Filing Date
2024-07-01
Accepted
2024-07-01 16:25:45
Documents
12
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A urgn20240606_def14a.htm DEF 14A 867588
2 actualceodirectcompensat.jpg GRAPHIC 25632
3 netlosstablev3.jpg GRAPHIC 28281
4 proxycardpg1of2.jpg GRAPHIC 117187
5 proxycardpg2of2.jpg GRAPHIC 88817
6 tsrtablev3.jpg GRAPHIC 26379
7 urgn20240606_def14aimg001.jpg GRAPHIC 8504
8 urgn20240606_def14aimg002.jpg GRAPHIC 2387
9 urgn20240606_def14aimg004.jpg GRAPHIC 27235
10 urgn20240606_def14aimg005.jpg GRAPHIC 5474
11 urgn20240606_def14aimg006.jpg GRAPHIC 5258
12 urgn20240606_def14aimg007.jpg GRAPHIC 5044
  Complete submission text file 0001437749-24-021722.txt   1335917
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38079 | Film No.: 241090978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)